Clinical Trial Update: Efficacy, Safety, and Tolerability of Ancrod in Patients With Sudden Hearing Loss [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial updates on ancrod for hearing loss evaluating efficacy, safety, and tolerability.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Deafness
• Ear Diseases
• Hearing Disorders
• Hearing Loss

Drugs mentioned

• Ancrod (ancrod)

Snippet

Sponsor: Nordmark Arzneimittel GmbH & Co. KG | Conditions: Hearing Loss, Deafness | Phase 1, Phase 2 | Status: COMPLETED